RZ358 (ersodetug) as a novel therapy for hypoglycemia due to tumor hyperinsulinism: outcomes from an expanded access program for compassionate use
Year: 2025
Type: conference-abstract
Source: Endocrine Abstracts
Authors: MD Jonathan Strosberg, MD, Mary-Elizabeth Patti, MD, Marilyn Tan, MD, Shagufta Shaheen,, Jairo Arturo Norena, MD, Armen Yerevanian, MD, Leah M Wilson, MD, Linda Lester, MD, Jasmine Sidhu, MD, Davelyn Eaves Hood, MD, Gopal Saha, MBBS, Brian Kenneth Roberts MD
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4408303220